共 11 条
- [4] The Cognitive and Negative Symptoms in Schizophrenia, Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (10): : 1593 - 1602
- [6] Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2019, 95
- [8] Long-lasting rescue of schizophrenia-relevant cognitive impairments via risperidone-loaded microPlates Drug Delivery and Translational Research, 2022, 12 : 1829 - 1842